JP Morgan Private Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,582
Closed -$634K 2023
2022
Q3
$634K Sell
2,582
-1,136
-31% -$307K ﹤0.01% 1360
2022
Q2
$920K Buy
3,718
+381
+11% +$103K ﹤0.01% 1180
2022
Q1
$1.1M Buy
3,337
+557
+20% +$171K ﹤0.01% 1175
2021
Q4
$998K Sell
2,780
-18
-0.6% -$6.08K ﹤0.01% 1244
2021
Q3
$911K Buy
2,798
+235
+9% +$79.6K ﹤0.01% 1257
2021
Q2
$800K Sell
2,563
-69
-3% -$21.2K ﹤0.01% 1297
2021
Q1
$839K Sell
2,632
-2,690
-51% -$861K ﹤0.01% 1118
2020
Q4
$1.73M Buy
5,322
+2,413
+83% +$667K 0.01% 795
2020
Q3
$806K Buy
2,909
+1,520
+109% +$438K ﹤0.01% 970
2020
Q2
$336K Buy
+1,389
New +$279K ﹤0.01% 1257

Other funds holding ABMD

JP Morgan Private Wealth Advisors's ABMD Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,582 shares — an estimated $634K sold.

JP Morgan Private Wealth Advisors first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $1.73M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 2,582 Abiomed Inc shares in Q4 2022, an estimated $634K.
  • JP Morgan Private Wealth Advisors first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • JP Morgan Private Wealth Advisors's Abiomed Inc position peaked at $1.73M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.